Dioxolane analogs for improved intercellular delivery

Details for Australian Patent Application No. 2002212015 (hide)

Owner SHIRE BIOCHEM INC

Inventors Bubenik, Monica; Attardo, Giorgio; Blais, Charles; Bubenik, Monica

Agent Davies Collison Cave

Pub. Number AU-B-2002212015

PCT Pub. Number WO02/30922

Priority 60/288,424 04.05.01 US; 60/239,885 13.10.00 US

Filing date 15 October 2001

Wipo publication date 22 April 2002

Acceptance publication date 25 January 2007

International Classifications

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/7068 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 473/18 (2006.01) Heterocyclic compounds containing purine ring systems

C07F 9/655 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6558 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6561 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

25 January 2007 Application Accepted

  Published as AU-B-2002212015

3 May 2007 Application for Amendment

  The nature of the amendment is: Amend the coinventor names to read: Bubenik, Monica; Attardo, Giorgio; Blais, Charles; Zacharie, Boulos; Rej, Rabindra; Lavallee, Jean-Francois; Vaillancourt, Louis; Denis, Real and Levesque Sophie.. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

16 August 2007 Amendment Made

  The nature of the amendment is: Amend the co-inventor names to read Bubenik, Monica; Zacharie, Boulos; Attardo, Giorgio; Vaillancourt, Louis; Blais, Charles; Rej, Rabindra; Lavallee, Jean-Francois; Levesque, Sophie and Denis, Real

16 August 2007 Standard Patent Sealed

8 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002212016-Method and apparatus for separating mixtures of organic and aqueous liquid phases

2002212014